{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P17813",
      "entity_text" : "end",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2244",
      "entity_text" : "aspirin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Low-dose aspirin therapy did not reduce primary end points in patients with eGFR> = 90 mL/min/1.73 m 2 (aspirin, 9/248; nonaspirin, 11/270; 0.94 [0.38-2.3]) or those with eGFR < 60 mL/min/1.73 m 2 (aspirin, 29/342; nonaspirin, 19/290; 1.3 [0.76-2.4]).",
  "reading_complete" : "2020-07-28T16:23:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:18:12Z",
  "trigger" : "reduce",
  "evidence" : [ "aspirin therapy did not reduce primary end" ],
  "pmc_id" : "3024334",
  "score" : 0
}